Stada Arzneimittel APAC News and Activities

Stada Arzneimittel APAC is owned by Capvest. Capvest has a direct presence in 6 countries.

Capvest has 6 subsidiaries including Clonmel Healthcare, Hemofarm and Natra.

They are in:

• Pharmaceuticals71%
• Fund14%
• Other14%

Acquisition, funding and merger involving Capvest.

• Capvest has acquired Stada Arzneimittel (posted on April 14 2026).

View the org chart displaying its 5 main executives

Most searched biographies at Stada Arzneimittel APAC

• Philippe Malecki, Deputy General Director, Vietnam
• Ding Xu, General Manager, Greater China
• Santana Panawattanakul, Country Manager, Thailand

Create your alert
to follow the executive moves at Stada Arzneimittel APAC.

Capvest has 1,917 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Ipsen has announced the acquisition of Memo Therapeutics  (posted on July 1 2026).
• Hanmi has acquired Aptose Biosciences (posted on July 1 2026).
• Zymeworks has announced the acquisition of Theravance Biopharma  (posted on June 29 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Tracey Franklin - Chief People and Digital Technology Officer at Moderna

Learn more about the Pharmaceuticals industry

Press releases by Stada Arzneimittel APAC

Social media about Stada Arzneimittel APAC

• Stada Arzneimittel APAC on Wikipedia, Google News & Yahoo Finance
• Stada Arzneimittel APAC on LinkedIn, X (Twitter) & YouTube